Lisa Adler

668 citations
12 papers · 510 indexed · h-index 8
Topics
Endometrial and Cervical Cancer Treatments (3 papers)HER2/EGFR in Cancer Research (3 papers)Cell Adhesion Molecules Research (2 papers)
Partner nations
United States

In The Last Decade

Lisa Adler

11 papers receiving 498 citations

Peers

Lisa Adler
Comparison fields: 5 of 75
  • Oncology 178
  • Obstetrics and Gynecology 170
  • Molecular Biology 156
  • Reproductive Medicine 125
  • Immunology and Allergy 77
Replace Tomokazu Umezu with:
Tomokazu Umezu Japan
Alexander Marmé Germany
Renske A. de Jong Netherlands
Raluca A. Budiu United States
Yunyan Sun China
Refika Yigit Netherlands
Erika Márton Austria
Cheng‐Yang Chou Taiwan
France Gauthier Canada
Hisamori Kato Japan
Lisa Adler relative to Tomokazu Umezu Japan Tomokazu Umezu's profile →
Citations per field
00.5×10×12.8×
Tomokazu Umezu · 1×
Citations per year

Countries citing papers authored by Lisa Adler

Since Specialization
Citations

This map shows the geographic impact of Lisa Adler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Adler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Adler more than expected).

Fields of papers citing papers by Lisa Adler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Adler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Adler. The network helps show where Lisa Adler may publish in the future.

Co-authorship network of co-authors of Lisa Adler

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Adler. A scholar is included among the top collaborators of Lisa Adler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Adler. Lisa Adler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 4
2 0
3 1
4 200
5 39
6 55
7 4
8 59
9 93
10 9
11 21
12 25

About Lisa Adler

Lisa Adler is a scholar working on Biological Psychiatry, Obstetrics and Gynecology and Immunology and Allergy, having authored 12 papers that have together received 510 indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (3 papers), HER2/EGFR in Cancer Research (3 papers) and Cell Adhesion Molecules Research (2 papers). The work is most often cited by research in Obstetrics and Gynecology (170 citations), Reproductive Medicine (125 citations) and Immunology and Allergy (77 citations). Lisa Adler has collaborated with scholars based in United States. Frequent co-authors include Janet S. Rader, Michael W. Sill, Mark R. Wick, Helen Liapis, Ira Horowitz, Jonathan S. Berek, Kathleen M. Darcy, J.T. Thigpen, Gini F. Fleming and James V. Fiorica. Their work appears in journals such as Cancer, American Journal of Obstetrics and Gynecology and Journal of the American Academy of Child & Adolescent Psychiatry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026